Find information on Industry Analysis Report

This report examines the market for vaccines used in humans to previous various types of disease. It covers only commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable; it does not cover emerging vaccines for diseases that are not currently vaccine-preventable, such as Alzheimer’s disease, diabetes, Ebola infection, Epstein-Barr virus (EBV) infection, ETEC infection, heart attach, Helicobacter pylori infection, multiple sclerosis, Parkinson’s disease, West Nile virus (WNV) infection, etc.; vaccines that address these and other not-yet-vaccine-preventable conditions are discussed in Kalorama’s new report, “What’s Next in Vaccines.” http://www.bharatbook.com/healthcare-market-research-reports/vaccines-2012-world-market-analysis-key-players-trends-pediatric-and-adult.html

The vaccine industry has seen changes in the past year, and these are covered in this report Vaccines 2012: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry. The high growth rates and successful launch of several products recently have kept interest in the global vaccine market high. The global market for vaccines experienced strong growth through 2011 and this is expected to continue through the forecast period. Growth is being fueled by new product introductions and rising usage in all regions. Business Report

Included in this report are current market size and forecast for the following vaccines:

Pediatric Vaccines:
Combinations
Hepatitis
HIB
MMR
Pneumococcal
Poliovirus
Varicella
Other Pediatric

Adult Vaccines: Cervical Cancer
Hepatitis
Influenza
Pneumococcal
Travel; DT; Misc.

Kalorama has expanded the global perspective of this report in this edition, including estimates of vaccine sales (pediatric and adult segments) in the following regions:

U.S.
Rest of North Amer.
South America
Europe
Japan
India
China
Rest of World

Despite ongoing improvements in pediatric vaccination, it is estimated that at least two million children die each year from diseases that could have been prevented by already existing vaccines. This problem is most significant in low income countries, with the health disparity between rich and poor countries resulting in average life spans of about 77 and 52 years, respectively. In addition to this high death toll, millions more suffer disability and illness because they have not been immunized. Adult immunization is an important, but frequently overlooked, part of patient care. Vaccination programs typically focus on children, yet adults in industrialized countries are more likely to die as a result of vaccine-preventable diseases than are children.

Key issues in the global vaccine market today include product safety, refusal to immunize, supply shortages, the use of vaccines to prevent pandemics and address bioterrorism, and innovations in vaccine delivery systems.The following issues are discussed in this report.

Vaccine Safety
Refusal to Immunize
Obesity
Post-Licensure Surveillance
The Future of Vaccine Safety
Vaccine Shortages
Preventing Pandemics
Project Bioshield Act
National Bio and Agro-Defense Facility
DNA Vaccination
Mucosal Delivery
Intranasal Delivery
Vaccine Patches
Vaccine Chips and Microneedles
Innovations in Vaccine Production
Nanoparticle Systems
Cloning

Vaccination protects not only individuals, but also entire communities from diseases spread by person-to-person transmission.For example, vaccination can prevent about 50% of deaths from pneumococcal disease and 80% of deaths from influenza-related complications in the elderly. Pharmacoeconomic studies have demonstrated the value of influenza and pneumococcal vaccines; however, immunization rates for these diseases continue to be low in the elderly populations. This report includes profiles of the key players in vaccines, including:

AlphaVax, Inc.
Bavarian Nordic A/S
Baxter Healthcare
Bharat Biotech
Crucell /Johnson & Johnson
Emergent biosolutions
GlaxoSmithKline
Medimmune
Merck & Co. Inc
Novartis
Sanofi Pasteur
Pfizer

CHAPTER ONE: EXECUTIVE SUMMARY
The Global Vaccine Industry Scope and Methodology
Overview
Pediatric Preventative Vaccines
The Market
Adult Preventative Vaccines
The Market
Total Market
Issues and Trends

CHAPTER TWO: INTRODUCTION TO VACCINES
A Brief History: The Development of Vaccines
The Immune Response
Mechanism of Action
Types of Vaccines
Attenuated (Weakened) Live Viruses
Killed (Inactivated) Viruses
Toxoid Vaccines
Genetically Engineered/Modified Vaccines
Vaccine Approval Process

CHAPTER THREE: PEDIATRIC PREVENTIVE VACCINES
Introduction
Childhood Immunization in the United States
Childhood Immunization Rates
Challenges to the Vaccine Delivery System
The Effect of U.S. Healthcare Reform
Recommended Childhood Immunization Schedule
State Immunization Recommendations
United Nations Initiatives
Pediatric Vaccine Products
BCG
Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio
Haemophilus Influenzae Type B
Hepatitis A
Measles, Mumps and Rubella
Meningococcal Disease
Pneumococcal Conjugate
Rotavirus
Varicella
Pediatric Vaccines in Development
Cost of Vaccines in the United States
The World Market for Pediatric Preventive Vaccines
Total Market Size and Forecast
Hepatitis Vaccine Market

For more information kindly visit :
Vaccines 2012 World Market Analysis, Key Players, Trends, Pediatric and Adult

Or

Bharat Book Bureau
Ph.: + 91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/#!/Sandhya3B
https://bharatbookblog.wordpress.com/

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Tag Cloud

%d bloggers like this: